Financials
- Market Capitalization 3.87 B
- Employee 145
- Founded 2015
- CEO N/A
- Website www.ideayabio.com
- Headquarter Delaware, United States
- FIGI BBG00CTZ4D83
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-27.01
Relación precio/flujo de caja
13.99
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1518 | TNGX Tango Therapeutics, Inc. - Common Stock | 23.34 USD | -7.67% | -1.10% | -11.46% | +253.10% | 3.94 B USD | ||
| 1532 | AMLX Amylyx Pharmaceuticals, Inc. - Common Stock | 34.74 USD | -6.56% | -10.09% | +76.43% | +277.61% | 3.87 B USD | ||
| 1541 | DNLI Denali Therapeutics Inc. - Common Stock | 24.00 USD | -2.72% | -3.54% | 0.00% | +48.42% | 3.84 B USD | ||
| 1544 | TLX Telix Pharmaceuticals Limited - American Depositary Shares | 11.29 USD | -0.79% | -1.48% | +12.45% | +78.92% | 3.82 B USD |